Quick Answer
Adaptive Biotechnologies Corp reported Shares Outstanding of 153.78 million shares for fiscal year 2025.
Adaptive Biotechnologies Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 153.78M | +4.1% |
| 2024 | 147.77M | +1.9% |
| 2023 | 145.08M | +1.4% |
| 2022 | 143.11M | +1.2% |
| 2021 | 141.39M | +2.7% |
| 2020 | 137.65M | +9.9% |
| 2019 | 125.24M | +875.3% |
| 2018 | 12.84M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 152.58M | +3.4% | +0.2% |
| June 30, 2025 | 152.23M | +3.2% | +0.2% |
| March 31, 2025 | 151.92M | +3.1% | +2.8% |
| December 31, 2024 | 147.77M | +1.9% | +0.1% |
| September 30, 2024 | 147.56M | +1.9% | +0.1% |
| June 30, 2024 | 147.46M | +1.9% | +0.1% |
| March 31, 2024 | 147.37M | +2.1% | +1.6% |
| December 31, 2023 | 145.08M | +1.4% | +0.2% |
- Adaptive Biotechnologies Corp showed an increase of +4.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Adaptive Biotechnologies Corp’s shares outstanding has grown by 1097.5% (from 12.84 million shares to 153.78 million shares).
- The most recent figure is from Adaptive Biotechnologies Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: